Department of Adult Surgery, KASSAB's Orthopedic Institute, University El Manar II, Tunisia.
Department of Orthopedic Surgery, SAHLOUL's Hospital, University of SOUSSE, Tunisia.
J Bone Oncol. 2015 Nov 10;4(4):115-23. doi: 10.1016/j.jbo.2015.07.002. eCollection 2015 Dec.
Surface osteosarcoma are rare variant of osteosarcoma that include parosteal osteosarcoma, periosteal osteosarcoma and high grade surface osteosarcoma. These lesions have different clinical presentation and biological behavior compared to conventional osteosarcoma, and hence need to be managed differently.
The aim of this study is to analyze the clinico-pathological features and outcome of a series of surface osteosarcoma in an attempt to define the adequate treatment of this rare entity.
It is a retrospective and bicentric study of 18 surface osteosarcoma that were seen at the KASSAB's Institute and SAHLOUL Hospital from 2006 to 2013. The authors reviewed the clinical and radiologic features, histologic sections, treatments, and outcomes in this group of patients.
Seven patients were male (38.9%) and 11 were female (61.1%) with mean age of 25 years (range from 16 to 55 years). Eleven lesions were in the femur and 7 in the tibia. We identified 11 parosteal osteosarcoma (six of them were dedifferentiated), 3 periosteal osteosarcoma and 4 high grade surface osteosarcoma. Six patients had neoadjuvant chemotherapy and all lesions had surgical resection. Margins were wide in 15 cases and intra lesional in 3 cases. Histological response to chemotherapy was poor in all cases. The mean follow up was 34.5 months. Six patients (33.3%) presented local recurrence and 8 patients (44.4%) presented lung metastases. Six patients (33.3%) died from the disease after a mean follow up of 12 months (6-30 months); all of them had high grade lesions.
Histological grade of malignancy is the main point to assess in surface osteosarcoma since it determines treatment and prognosis. Low grade lesions should be treated by wide resection, while high grade lesions need more aggressive surgical approach associated to post operative chemotherapy.
表面骨肉瘤是骨肉瘤的罕见变异型,包括骨旁骨肉瘤、骨膜骨肉瘤和高级别表面骨肉瘤。这些病变与传统骨肉瘤的临床表现和生物学行为不同,因此需要不同的治疗方法。
本研究旨在分析一系列表面骨肉瘤的临床病理特征和结果,旨在确定这种罕见实体的适当治疗方法。
这是一项回顾性和双中心研究,共纳入了 2006 年至 2013 年在 KASSAB 研究所和 SAHLOUL 医院就诊的 18 例表面骨肉瘤患者。作者回顾了这组患者的临床和影像学特征、组织学切片、治疗和结果。
7 例患者为男性(38.9%),11 例为女性(61.1%),平均年龄为 25 岁(16-55 岁)。11 例病变位于股骨,7 例位于胫骨。我们发现 11 例骨旁骨肉瘤(其中 6 例为去分化型)、3 例骨膜骨肉瘤和 4 例高级别表面骨肉瘤。6 例患者接受了新辅助化疗,所有病变均行手术切除。15 例边缘广泛,3 例边缘局限。所有病例对化疗的组织学反应均较差。平均随访时间为 34.5 个月。6 例(33.3%)患者出现局部复发,8 例(44.4%)患者出现肺转移。6 例(33.3%)患者在平均 12 个月(6-30 个月)的随访后死于疾病,均为高级别病变。
组织学恶性程度是评估表面骨肉瘤的主要因素,因为它决定了治疗和预后。低级别病变应采用广泛切除,而高级别病变需要更积极的手术方法,并结合术后化疗。